Literature DB >> 17514475

[German Environmental Survey for Children (GerES IV) in the German Health Interview and Examination Survey for Children and Adolescents (KiGGS). First results].

C Schulz1, U Wolf, K Becker, A Conrad, A Hünken, A Lüdecke, M Müssig-Zufika, S Riedel, I Seiffert, M Seiwert, M Kolossa-Gehring.   

Abstract

The German Environmental Survey for Children (GerES IV) is the environment-related module of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS) of the Robert Koch Institute and the fourth GerES of the Federal Environment Agency. The main objective of GerESs is to analyse and document the extent, distribution and determinants of exposure to environmental pollutants of the German general population. GerES IV was performed from 2003 to 2006. A total of 1.790 children aged 3-14 years from 150 sampling locations participated in GerES IV. Samples of blood, urine, tap water, house dust and indoor air were analysed. Hearing tests, measurements of traffic noise and interviews to get exposure-related information were conducted. First results indicate a clear decrease of the exposure to arsenic, lead and mercury. Cotinine concentrations in urine can be used to classify the exposure of children to environmental tobacco smoke. The examination of the tap water used in the subjects' households indicates that in some households the guideline values of the German Drinking Water Ordinance were not always met. This is the case for nickel, copper and lead which are used as pipe material for domestic plumbing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17514475     DOI: 10.1007/s00103-007-0252-4

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  1 in total

1.  Quality management for the collection of biological samples in multicentre studies.

Authors:  J Peplies; A Fraterman; R Scott; P Russo; K Bammann
Journal:  Eur J Epidemiol       Date:  2010-06-22       Impact factor: 8.082

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.